Cited by 3Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesMindfulness and Compassion Interventions

Effects of live-online, group mindfulness training on opioid use and anxiety during buprenorphine treatment: A comparative effectiveness RCT

Open access
Rosansky, Joseph A., Howard, Leah, Goodman, Hannah, Okst, Kayley, Fatkin, Thomas, Fredericksen, A. Kiera, Sokol, Randi, Gardiner, Paula +4 more·2024·Contemporary Clinical Trials

Abstract

Background Office-based opioid treatment with buprenorphine has emerged as a popular evidence-based treatment for opioid use disorder. Unfortunately, psychosocial stress, anxiety, pain, and co-morbid substance use increase patients' risk for relapse. We designed this study to compare the effects of complementing buprenorphine treatment with 24 weeks of a live-online Mindful Recovery Opioid Care Continuum (M-ROCC) group to a time and attention-matched, live-online Recovery Support Group (RSG) active control condition.Methods We plan to enroll a maximum of N = 280 and randomize at least N = 192 patients prescribed buprenorphine through referrals from office-based and telemedicine buprenorphine treatment providers and social media advertisements. Participants will be randomly assigned to M-ROCC or RSG and will be blinded to their treatment condition. The primary outcome for this study will be biochemically confirmed periods of abstinence from illicit opioids, as measured by self-reported use and randomly collected, video-observed oral fluid toxicology testing during the final 12 weeks of study participation. Secondary outcomes include changes in Patient-Reported Outcomes Measurement Information System (PROMIS) anxiety and pain interference scores between baseline and week 24.Results The trial was funded by the National Institutes of Health, HEAL Initiative through NCCIH (R33AT010125). Data collection is projected to end by September 2023, and we expect publication of results in 2024.Conclusion If the M-ROCC intervention is found to be effective in this format, it will demonstrate that live-online mindfulness groups can improve outcomes and address common co-morbidities like anxiety and pain during buprenorphine treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cct.2023.107417

Cites

71 of 72 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In addictions, mindfulness has shown a direct relationship between mindfulness and abstinence.

    “Specifically, in the case of addictions, mindfulness has shown a direct relationship between mindfulness and abstinence [51].”

    From Third-Generation Therapies for the Management of Psychoactive Substance Use in Young People: Scoping Review (2024) · cites this paper as [51]

    The Introduction (page unavailable) reports that a mindfulness-based intervention reduced opioid cravings and use in one methadone-treated group. It also says mindfulness interventions did not consistently improve key substance-use outcomes. The paper therefore offers some support for a link between mindfulness-based treatment and reduced use, but not for an established direct relationship between mindfulness and abstinence. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. [26]Garland EL. Mindfulness-Oriented Recovery Enhancement for Addiction, Stress, and Pain. 1st ed. NASW Press; 2013.
  2. [36]Rosansky JA, Borodovsky J, Phillips J, Attitudes and experiences of patients engaged in buprenorphine treatment in Massachusetts during the COVID-19 pandemic. In: Collaborative Perspectives on Addiction. American Psychological Association Division 50; 2022: 1.
  3. [54]Beck JS. Cognitive Behavioral Therapy: Basics and Beyond. 2nd ed. Guilford Press; 2011.
  4. [67]Marsch LA, Moore SK, Borodovsky JT, A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults. Addiction. 2016; 111(8): 1406– 1415. doi: 10.1111/add.13363 26918564 PMC4940230 · DOI

Cited by

Sorted by citations

Authors
Rosansky, J. A., Howard, L., Goodman, H., Okst, K., Fatkin, T., Fredericksen, A. K., Sokol, R., Gardiner, P., Parry, G., Cook, B. L., Weiss, R. D., & Schuman-Olivier, Z. D.
Affiliations
  • Cambridge Health Alliance (US)
  • Tufts University (US)
  • Harvard University (US)
Venue
Contemporary Clinical Trials
Publisher
Elsevier BV
Published
2024-02
Volume
137
Pages
107417
ISSN
1551-7144 (ISSN-L)
OpenAlex
W4389990393
Cited by
3
References
72
Citations by year
2025: 2 · 2024: 1
FWCI
0.77
Type
journal article
Language
en
Open access
Locations
  • Contemporary Clinical Trials (publishedVersion)
  • SSRN Electronic Journal (acceptedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Center for Complementary and Integrative Health
  • National Institutes of Health (T32AT000051, UG1 DA15831)
  • National Institute on Drug Abuse
  • National Institute of Neurological Disorders and Stroke
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
Keywords
mindfulness training, buprenorphine, opioid use disorder, opioid use disorder treatment, anxiety, pain interference, opioid abstinence, relapse prevention
MeSH terms
Analgesics, Opioid, Anxiety, Buprenorphine, Humans, Opioid-Related Disorders, Neoplasm Recurrence, Local, Pain, Mindfulness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review